Abano Healthcare Group Limited (NZX: ABA) Announces Increased Scheme Price to $5.20 Per Share

Wednesday 11th November 2020

Listed trans-Tasman dental company, Abano Healthcare Group Limited, announces that Adams NZ Bidco Limited has agreed to increase its headline Scheme price for Abano shares from $4.75 per Abano share to $5.20 per share.

The increased Scheme price remains subject to the price adjustment regime described in the Scheme Booklet and, therefore, the Scheme price could be reduced if an Adjustment Event occurs prior to implementation of the Scheme.

The Board has updated its FY21 guidance as a result of strong trading for October 2020.

The Board unanimously recommends that shareholders vote in favour of the Scheme in the absence of a superior proposal. Each Abano Director who holds or controls Abano shares intends to vote all of such shares in favour of the Scheme, subject to the same qualification.

The Scheme Meeting date has been moved to 25 November 2020, to allow for shareholders to receive and consider updated information before voting.

See the links below for more details:

Letter from the Chair

Supplementary Scheme Booklet including addendum to Independent Adviser's Report

New Virtual Meeting Guide - 25 November 2020

Proxy Form

Announcement - Abano Announces Increased Scheme Price

Scheme Variation Agreement - November 2020

Court Order

Source: Abano Healthcare Group Limited

Comments from our readers

No comments yet